Miriam Lichtner

Pubblicazioni

Titolo	Pubblicato in	Anno
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES	2016
Herpes virus reactivation after initiation of interferon-free antiviral agents in HIV-HCV-coinfected subjects: a new immune restoration disease?	ANTIVIRAL THERAPY	2016
Abstracts of ICI 2016 International Congress of Immunology, 21-26 August 2016, Melbourne, Australia	EUROPEAN JOURNAL OF IMMUNOLOGY	2016
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice	PLOS ONE	2016
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015	NEW MICROBIOLOGICA	2016
Infection-related and -unrelated malignancies, HIV and the aging population	HIV MEDICINE	2016
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort	PLOS ONE	2016
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels	JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY	2016
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort	CLINICAL MICROBIOLOGY AND INFECTION	2016
HCV-related diabetes: Still looking for a definition	CLINICAL MICROBIOLOGY AND INFECTION	2016
Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression: A prospective cohort study	MEDICINE	2016
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy	JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES	2016
Baseline myeloid and lymphoid activation markers can predict time to viral load reduction under 50 copies/mL and CD4 recovery, respectively, after highly active antiretroviral therapy initiation	JOURNAL OF THE INTERNATIONAL AIDS SOCIETY	2016
Cardiovascular risk in HIV-positive subjects: analyses of T-cell phenotype and CD49d expression	JOURNAL OF THE INTERNATIONAL AIDS SOCIETY	2016
In the ERA of New Direct Acting Antiviral Agents HCV Sequencing Allows the Most Accurate Subtype and Genotype Assignment	JOURNAL OF HEPATOLOGY	2016
HBV-HDV Co-Infection Constrains HBV Genetic Evolution in HBsAg	JOURNAL OF HEPATOLOGY	2016
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study	THE LANCET. HIV	2016
HBsAg genetic elements critical for immune escape correlate with HBV-reactivation upon immunosuppression	HEPATOLOGY	2015
Multifunctional analysis of CD4+T-cell response as immune-based model for tuberculosis detection	JOURNAL OF IMMUNOLOGY RESEARCH	2015
Genotypic tropism testing in HIV-1 proviral DNA can provide useful information at low-level viremia	JOURNAL OF CLINICAL MICROBIOLOGY	2015

Pubblicazioni

Progetti di Ricerca